# Fat Distribution in Healthy Early Postmenopausal Women

> **NCT00335218** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 67 (actual)

## Conditions studied

- Healthy
- Postmenopause

## Interventions

- **DRUG:** Climodien / Lafamme (BAY86-5027)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00335218
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335218, "Fat Distribution in Healthy Early Postmenopausal Women". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00335218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*